These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 22731793

  • 1. Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy.
    Liu L, Wan X, Liu J, Huang Z, Cao X, Li Y.
    Diabetes Technol Ther; 2012 Sep; 14(9):756-61. PubMed ID: 22731793
    [Abstract] [Full Text] [Related]

  • 2. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function.
    Li Y, Xu W, Liao Z, Yao B, Chen X, Huang Z, Hu G, Weng J.
    Diabetes Care; 2004 Nov; 27(11):2597-602. PubMed ID: 15504992
    [Abstract] [Full Text] [Related]

  • 3. Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission.
    Liu L, Ke W, Wan X, Zhang P, Cao X, Deng W, Li Y.
    Diabetes Res Clin Pract; 2015 May; 108(2):250-7. PubMed ID: 25765670
    [Abstract] [Full Text] [Related]

  • 4. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
    Chan CL, Pyle L, Kelsey MM, Newnes L, Baumgartner A, Zeitler PS, Nadeau KJ.
    Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
    [Abstract] [Full Text] [Related]

  • 5. Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control.
    Yamanouchi T, Ogata N, Tagaya T, Kawasaki T, Sekino N, Funato H, Akaoka L, Miyashita H.
    Lancet; 1996 Jun 01; 347(9014):1514-8. PubMed ID: 8684103
    [Abstract] [Full Text] [Related]

  • 6. Fasting plasma glucose after intensive insulin therapy predicted long-term glycemic control in newly diagnosed type 2 diabetic patients.
    Liu J, Liu J, Fang D, Liu L, Huang Z, Wan X, Cao X, Li Y.
    Endocr J; 2013 Jun 01; 60(6):725-32. PubMed ID: 23428844
    [Abstract] [Full Text] [Related]

  • 7. Attitudes toward diabetes affect maintenance of drug-free remission in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion treatment.
    Chen A, Huang Z, Wan X, Deng W, Wu J, Li L, Cai Q, Xiao H, Li Y.
    Diabetes Care; 2012 Mar 01; 35(3):474-81. PubMed ID: 22228747
    [Abstract] [Full Text] [Related]

  • 8. Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay.
    McGill JB, Cole TG, Nowatzke W, Houghton S, Ammirati EB, Gautille T, Sarno MJ, U.S. trial of the GlycoMark assay.
    Diabetes Care; 2004 Aug 01; 27(8):1859-65. PubMed ID: 15277408
    [Abstract] [Full Text] [Related]

  • 9. Remission of hyperglycemia following intensive insulin therapy in newly diagnosed type 2 diabetic patients: a long-term follow-up study.
    Xu W, Li YB, Deng WP, Hao YT, Weng JP.
    Chin Med J (Engl); 2009 Nov 05; 122(21):2554-9. PubMed ID: 19951569
    [Abstract] [Full Text] [Related]

  • 10. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.
    Weng J, Li Y, Xu W, Shi L, Zhang Q, Zhu D, Hu Y, Zhou Z, Yan X, Tian H, Ran X, Luo Z, Xian J, Yan L, Li F, Zeng L, Chen Y, Yang L, Yan S, Liu J, Li M, Fu Z, Cheng H.
    Lancet; 2008 May 24; 371(9626):1753-60. PubMed ID: 18502299
    [Abstract] [Full Text] [Related]

  • 11. Predictors of Long-Term Glycemic Remission After 2-Week Intensive Insulin Treatment in Newly Diagnosed Type 2 Diabetes.
    Wang H, Kuang J, Xu M, Gao Z, Li Q, Liu S, Zhang F, Yu Y, Liang Z, Zhao W, Yang G, Li L, Wang Y, Li G.
    J Clin Endocrinol Metab; 2019 Jun 01; 104(6):2153-2162. PubMed ID: 30629195
    [Abstract] [Full Text] [Related]

  • 12. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment.
    Ilkova H, Glaser B, Tunçkale A, Bagriaçik N, Cerasi E.
    Diabetes Care; 1997 Sep 01; 20(9):1353-6. PubMed ID: 9283777
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of saxagliptin add-on therapy to insulin on blood glycemic fluctuations in patients with type 2 diabetes: A randomized, control, open-labeled trial.
    Li FF, Jiang LL, Yan RN, Zhu HH, Zhou PH, Zhang DF, Su XF, Wu JD, Ye L, Ma JH.
    Medicine (Baltimore); 2016 Oct 01; 95(43):e5229. PubMed ID: 27787387
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hypoglycemia during Short-Term Intensive Insulin Therapy and Its Association with Long-Term Glycemic Remission in Patients with Newly Diagnosed Type 2 Diabetes.
    Xu L, Zhang P, Huang Z, Zhong L, Li H, Liu L, Liu J, Xiao H, Li Y.
    J Diabetes Res; 2020 Oct 01; 2020():4097469. PubMed ID: 32149152
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy.
    Chen HS, Wu TE, Jap TS, Hsiao LC, Lee SH, Lin HD.
    Diabetes Care; 2008 Oct 01; 31(10):1927-32. PubMed ID: 18556343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.